A Registered Cohort Study on α-Synucleinopathy
α-Synucleinopathy is a cluster of neurodegenerative disease with motor and non-motor symptom. The data to be collected is intended to help healthcare providers make important medical decisions concerning α-synucleinopathy, through an enhanced understanding of the natural history, progression and multi-omics datasets of α-synucleinopathy.
Study identifier: NCT05527067. Status: RECRUITING.
Eligibility
Criteria: Inclusion Criteria: * Participants with a clinical diagnosis of primary α-synucleinopathy * Unrelated healthy controls Exclusion Criteria: * Patients with secondary α-synucleinopathy that cannot be excluded. * Patients with other neurological disorders. * Pregnant or lactating women.
- Minimum age: 30 Years
- Maximum age: 80 Years
Participating locations
- Fujian Medical University Union Hospital, Fuzhou, Fujian
Study records are sourced from ClinicalTrials.gov. Confirm current eligibility, recruiting status, and locations in the official record.